Cargando…
Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials
BACKGROUND: The increasing use of engineered nanomaterials (ENMs) of varying physical and chemical characteristics poses a great challenge for screening and assessing the potential pathology induced by these materials, necessitating novel toxicological approaches. Toxicogenomics measures changes in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865099/ https://www.ncbi.nlm.nih.gov/pubmed/27169501 http://dx.doi.org/10.1186/s12989-016-0137-5 |
_version_ | 1782431728616341504 |
---|---|
author | Nikota, Jake Williams, Andrew Yauk, Carole L. Wallin, Håkan Vogel, Ulla Halappanavar, Sabina |
author_facet | Nikota, Jake Williams, Andrew Yauk, Carole L. Wallin, Håkan Vogel, Ulla Halappanavar, Sabina |
author_sort | Nikota, Jake |
collection | PubMed |
description | BACKGROUND: The increasing use of engineered nanomaterials (ENMs) of varying physical and chemical characteristics poses a great challenge for screening and assessing the potential pathology induced by these materials, necessitating novel toxicological approaches. Toxicogenomics measures changes in mRNA levels in cells and tissues following exposure to toxic substances. The resulting information on altered gene expression profiles, associated pathways, and the doses at which these changes occur, are used to identify the underlying mechanisms of toxicity and to predict disease outcomes. We evaluated the applicability of toxicogenomics data in identifying potential lung-specific (genomic datasets are currently available from experiments where mice have been exposed to various ENMs through this common route of exposure) disease outcomes following exposure to ENMs. METHODS: Seven toxicogenomics studies describing mouse pulmonary responses over time following intra-tracheal exposure to increasing doses of carbon nanotubes (CNTs), carbon black, and titanium dioxide (TiO(2)) nanoparticles of varying properties were examined to understand underlying mechanisms of toxicity. mRNA profiles from these studies were compared to the publicly available datasets of 15 other mouse models of lung injury/diseases induced by various agents including bleomycin, ovalbumin, TNFα, lipopolysaccharide, bacterial infection, and welding fumes to delineate the implications of ENM-perturbed biological processes to disease pathogenesis in lungs. RESULTS: The meta-analysis revealed two distinct clusters—one driven by TiO(2) and the other by CNTs. Unsupervised clustering of the genes showing significant expression changes revealed that CNT response clustered with bleomycin injury and bacterial infection models, both of which are known to induce lung fibrosis, in a post-exposure-time dependent manner, irrespective of the CNT’s physical-chemical properties. TiO(2) samples clustered separately from CNTs and disease models. CONCLUSIONS: These results indicate that in the absence of apical toxicity data, a tiered strategy beginning with short term, in vivo tissue transcriptomics profiling can effectively and efficiently screen new ENMs that have a higher probability of inducing pulmonary pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12989-016-0137-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4865099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48650992016-05-13 Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials Nikota, Jake Williams, Andrew Yauk, Carole L. Wallin, Håkan Vogel, Ulla Halappanavar, Sabina Part Fibre Toxicol Research BACKGROUND: The increasing use of engineered nanomaterials (ENMs) of varying physical and chemical characteristics poses a great challenge for screening and assessing the potential pathology induced by these materials, necessitating novel toxicological approaches. Toxicogenomics measures changes in mRNA levels in cells and tissues following exposure to toxic substances. The resulting information on altered gene expression profiles, associated pathways, and the doses at which these changes occur, are used to identify the underlying mechanisms of toxicity and to predict disease outcomes. We evaluated the applicability of toxicogenomics data in identifying potential lung-specific (genomic datasets are currently available from experiments where mice have been exposed to various ENMs through this common route of exposure) disease outcomes following exposure to ENMs. METHODS: Seven toxicogenomics studies describing mouse pulmonary responses over time following intra-tracheal exposure to increasing doses of carbon nanotubes (CNTs), carbon black, and titanium dioxide (TiO(2)) nanoparticles of varying properties were examined to understand underlying mechanisms of toxicity. mRNA profiles from these studies were compared to the publicly available datasets of 15 other mouse models of lung injury/diseases induced by various agents including bleomycin, ovalbumin, TNFα, lipopolysaccharide, bacterial infection, and welding fumes to delineate the implications of ENM-perturbed biological processes to disease pathogenesis in lungs. RESULTS: The meta-analysis revealed two distinct clusters—one driven by TiO(2) and the other by CNTs. Unsupervised clustering of the genes showing significant expression changes revealed that CNT response clustered with bleomycin injury and bacterial infection models, both of which are known to induce lung fibrosis, in a post-exposure-time dependent manner, irrespective of the CNT’s physical-chemical properties. TiO(2) samples clustered separately from CNTs and disease models. CONCLUSIONS: These results indicate that in the absence of apical toxicity data, a tiered strategy beginning with short term, in vivo tissue transcriptomics profiling can effectively and efficiently screen new ENMs that have a higher probability of inducing pulmonary pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12989-016-0137-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-11 /pmc/articles/PMC4865099/ /pubmed/27169501 http://dx.doi.org/10.1186/s12989-016-0137-5 Text en © Nikota et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Nikota, Jake Williams, Andrew Yauk, Carole L. Wallin, Håkan Vogel, Ulla Halappanavar, Sabina Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials |
title | Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials |
title_full | Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials |
title_fullStr | Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials |
title_full_unstemmed | Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials |
title_short | Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials |
title_sort | meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865099/ https://www.ncbi.nlm.nih.gov/pubmed/27169501 http://dx.doi.org/10.1186/s12989-016-0137-5 |
work_keys_str_mv | AT nikotajake metaanalysisoftranscriptomicresponsesasameanstoidentifypulmonarydiseaseoutcomesforengineerednanomaterials AT williamsandrew metaanalysisoftranscriptomicresponsesasameanstoidentifypulmonarydiseaseoutcomesforengineerednanomaterials AT yaukcarolel metaanalysisoftranscriptomicresponsesasameanstoidentifypulmonarydiseaseoutcomesforengineerednanomaterials AT wallinhakan metaanalysisoftranscriptomicresponsesasameanstoidentifypulmonarydiseaseoutcomesforengineerednanomaterials AT vogelulla metaanalysisoftranscriptomicresponsesasameanstoidentifypulmonarydiseaseoutcomesforengineerednanomaterials AT halappanavarsabina metaanalysisoftranscriptomicresponsesasameanstoidentifypulmonarydiseaseoutcomesforengineerednanomaterials |